Plain-English translation of NCT06693570 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing a medical device made from processed fish skin called an Intact Fish Skin Graft (IFSG) to see if it helps heal stubborn venous leg ulcers that haven't improved with standard treatment. Some participants will receive the fish skin graft along with standard wound care, while others will receive only standard care. The goal is to find out whether adding this treatment helps wounds heal faster and better.
Venous leg ulcers can be difficult to heal with standard care alone, and many patients struggle with wounds that don't improve even after weeks or months of treatment. This trial is exploring whether the fish skin graft can give stubborn wounds the extra help they need to finally close and heal.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to one of two groups: one receiving the fish skin graft plus standard wound care, or one receiving standard care alone. Either way, you'll attend weekly study visits for up to 12 visits, where your wound will be cleaned, assessed, and managed. Standard care includes wound cleaning, removal of dead tissue, moisture management, and compression therapy to support healing.
AI-generated summary from trial data · Aug 22, 2026 · Not medical advice
United States